128 related articles for article (PubMed ID: 38101446)
1. Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program.
Wisse PHA; de Boer SY; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Dekker E; Spaander MCW
Endoscopy; 2024 May; 56(5):364-372. PubMed ID: 38101446
[TBL] [Abstract][Full Text] [Related]
2. Causes of Post-Colonoscopy Colorectal Cancers Based on World Endoscopy Organization System of Analysis.
Anderson R; Burr NE; Valori R
Gastroenterology; 2020 Apr; 158(5):1287-1299.e2. PubMed ID: 31926170
[TBL] [Abstract][Full Text] [Related]
3. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.
Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW
Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114
[TBL] [Abstract][Full Text] [Related]
4. Root-cause Analysis of 762 Danish Post-colonoscopy Colorectal Cancer Patients.
Troelsen FS; Sørensen HT; Pedersen L; Brix LD; Grode LB; Dekker E; Erichsen R
Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3160-3169.e5. PubMed ID: 37031719
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Post-Colonoscopy Colorectal Cancer and Its Subtypes in a Screening Programme.
Unanue-Arza S; Idigoras-Rubio I; Fernández-Landa MJ; Bilbao-Iturribarria I; Bujanda L; Portillo I
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680254
[TBL] [Abstract][Full Text] [Related]
6. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
7. Utilization and reproducibility of World Endoscopy Organization post-colonoscopy colorectal cancer algorithms: retrospective analysis.
Beaton D; Beintaris I; Rutter MD
Endoscopy; 2022 Mar; 54(3):270-277. PubMed ID: 33682892
[TBL] [Abstract][Full Text] [Related]
8. Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization system.
Gimeno-García AZ; Hernández-Pérez A; Benítez F; Segura N; Nicolás-Pérez D; Quintero E; Hernández-Álvarez N; Betancor I; Salido E; Hernández-Guerra M
Gastroenterol Hepatol; 2024 Apr; 47(4):319-326. PubMed ID: 37285934
[TBL] [Abstract][Full Text] [Related]
9. Temporal Trends and Risk Factors for Postcolonoscopy Colorectal Cancer.
Uche-Anya EN; DeCuir N; Lebwohl B
J Clin Gastroenterol; 2019 Sep; 53(8):e334-e340. PubMed ID: 30119092
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Classification of Postcolonoscopy Colorectal Cancers in Inflammatory Bowel Disease: A Dutch Population-Based Cohort Study.
Wintjens DSJ; Bogie RMM; van den Heuvel TRA; le Clercq CMC; Oostenbrug LE; Romberg-Camps MJL; Straathof JW; Stassen LPS; Masclee AAM; Jonkers DMAE; Sanduleanu-Dascalescu S; Pierik MJ
J Crohns Colitis; 2018 Jun; 12(7):777-783. PubMed ID: 29648663
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.
Bronzwaer MES; Depla ACTM; van Lelyveld N; Spanier BWM; Oosterhout YH; van Leerdam ME; Spaander MCW; Dekker E;
Gastrointest Endosc; 2019 Jan; 89(1):1-13. PubMed ID: 30240879
[TBL] [Abstract][Full Text] [Related]
12. Post-colonoscopy colorectal cancer: A population-based cohort study of fecal occult blood test-positive colonoscopies.
Denis B; Bertolaso A; Gendre I; Perrin P; Hammas K
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102285. PubMed ID: 38246488
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers.
Samadder NJ; Neklason D; Snow A; Samowitz W; Cessna MH; Rowe K; Sandhu I; Boucher K; Pappas L; Smith KR; Wong J; Curtin K; Provenzale D; Burt RW
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2731-2739.e2. PubMed ID: 30930275
[TBL] [Abstract][Full Text] [Related]
14. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
[TBL] [Abstract][Full Text] [Related]
15. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
16. Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study.
Zorzi M; Antonelli G; Barbiellini Amidei C; Battagello J; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rosa-Rizzotto E; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rex DK; Rugge M; Hassan C; ; Giacomin A; Buda A; Costa D; Checchin D; Marin R; Patarnello E; Ceriani A; Guido E; Bertomoro P; Merlini N; Murer F; Ntakirutimana E; Benazzato L; Bellocchi MCC
Ann Intern Med; 2023 Mar; 176(3):303-310. PubMed ID: 36802754
[TBL] [Abstract][Full Text] [Related]
17. Postcolonoscopy Colorectal Cancer in Sweden From 2003 to 2012: Survival, Tumor Characteristics, and Risk Factors.
Forsberg A; Widman L; Bottai M; Ekbom A; Hultcrantz R
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2724-2733.e3. PubMed ID: 32553903
[TBL] [Abstract][Full Text] [Related]
18. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
19. World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.
Rutter MD; Beintaris I; Valori R; Chiu HM; Corley DA; Cuatrecasas M; Dekker E; Forsberg A; Gore-Booth J; Haug U; Kaminski MF; Matsuda T; Meijer GA; Morris E; Plumb AA; Rabeneck L; Robertson DJ; Schoen RE; Singh H; Tinmouth J; Young GP; Sanduleanu S
Gastroenterology; 2018 Sep; 155(3):909-925.e3. PubMed ID: 29958856
[TBL] [Abstract][Full Text] [Related]
20. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
